Matthew S. Ning

Extended Survival and Prognostic Factors for Patients With <i>ALK</i>-Rearranged Non–Small-Cell Lung Cancer and Brain Metastasis

Kimberly L. Johung, Norman Yeh, Neil Desai et al. · Journal of Clinical Oncology · 2015 · 331 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery

Joe Y. Chang, Reza J. Mehran, Lei Feng et al. · The Lancet Oncology · 2021 · 312 citations · Full text

Medicine, Oncology, Radiation Oncology +13

High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial

Roshal R. Patel, Kewen He, Hampartsoum B. Barsoumian et al. · Radiotherapy and Oncology · 2021 · 92 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer

Matthew S. Ning, Vamsi Ahobila, Anuja Jhingran et al. · Gynecologic Oncology · 2017 · 78 citations

Medicine, Oncology, Radiation Oncology +14

Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer

Matthew S. Ning, Ling‐Long Tang, Daniel R. Gomez et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 68 citations · Full text

Medicine, Oncology, Radiation Oncology +11